Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumonia

The results from the need to develop methodologies for performing cost analysis in developing countries, principally in the region of Latin America, were studied. It, furthermore, serves to generate knowledge from an economic evaluation in order to support decision-making related to the organization of health systems, particularly in the efficient use of resources which are allocated for the provision of medical services. Two chronic diseases (breast cancer and cardiac valve disease) and two infections (enteritis and bronchopneumonia) were selected for the study. The results recommend the use of a valid methodology for economic cost analysis of any disease to be studied and the use of this information in the decision-making process.

Sensing Cloud Optimization to Solve ED of Units with Valve-Point Effects and Multi-fuels

In this paper a solution to an highly constrained and non-convex economical dispatch (ED) problem with a meta-heuristic technique named Sensing Cloud Optimization (SCO) is presented. The proposed meta-heuristic is based on a cloud of particles whose central point represents the objective function value and the remaining particles act as sensors "to fill" the search space and "guide" the central particle so it moves into the best direction. To demonstrate its performance, a case study with multi-fuel units and valve- point effects is presented.

Caracterização de águas do processo e optimização dos consumos de água nos vários circuitos da Petibol, S.A. – Embalagens de Plástico

A empresa Petibol, S.A. – Embalagens de plástico centra-se na produção de embalagens de plástico a partir da matéria-prima Poliestireno Expandido (EPS) e Polipropileno Expandido (EPP). A empresa possui uma preocupação ao nível da qualidade da água e do aproveitamento energético, tendo desta forma surgido a realização do estudo na unidade industrial, com o objectivo de anular e/ou diminuir as possíveis lacunas existentes na unidade industrial. Numa primeira etapa foi realizada uma caracterização global à qualidade da água e à empresa, actualizando-se os esquemas já existentes, contabilizando-se os custos actuais relativamente aos processos no circuito da água (arrefecimento, aquecimento e pressurização), e por fim, efectuou-se um levantamento in loco do circuito de água, relativamente à pressão, temperatura e caudal. Numa fase posterior, foram propostos equipamentos e processos, tendo em vista a colmatação dos problemas identificados, realizando-se um subsequente estudo relativamente aos custos inerentes a esses novos processos. A caracterização à água foi avaliada em diferentes pontos do circuito industrial, tendo-se determinado na Sala de Bombagem que o filtro de areia não possuía as dimensões mais apropriadas, existindo também um problema a nível mecânico associado ao processo de contra-lavagem. Tais factos podem ser a causa da ocorrência de um aumento do teor de sólidos após a passagem na camada filtrante. Relativamente ao amaciador, este deveria amaciar de forma completa a água para alimentação à caldeira, embora se tenha registado à saída do amaciador uma dureza de 21,3 mg/L, denunciando problemas na troca iónica. No que toca à água de alimentação à caldeira, verifica-se a existência de parâmetros que não se encontram de acordo com os critérios enunciados para uma óptima qualidade, sendo eles o pH (10,14), condutividade (363 μS/cm), teor de ferro (1,21 mg/L) e a dureza (16 mg/L). De salientar que somente o teor de cobre, que se encontra em quantidades vestigiais, apresenta-se de acordo com os valores impostos. No que respeita à água da caldeira, esta apresenta parâmetros incompatíveis com os recomendados, sendo eles a condutividade (7350 μS/cm), teor de sólidos dissolvidos (5248 mg/L) e alcalinidade total (780 mg/L). De referir que o valor de pH (11,8) não se encontra de acordo com a aplicação do tratamento “fosfato-pH coordenado”. Em relação aos parâmetros com valores que se encontram dentro dos limites, estes correspondem à dureza (0 mg/L), ao teor de fosfatos (45 mg/L) e teor de sílica (0 mg/L). A água do circuito de arrefecimento foi sujeita a uma análise microbiológica, que corroborou a presença de um biofilme. Um dos problemas enunciados pela empresa, prendia-se com a impossibilidade de descarga, no colector municipal, dos condensados dos compressores, visto apresentarem uma quantidade de óleo de cerca de 43,3 mg/L, equivalente a quatro vezes o valor limite de emissão, de acordo com a legislação municipal. Por fim, o efluente de descarga industrial apresenta um valor de pH (10,3) acima do intervalo permitido por lei (6,0 – 9,0), sendo que a corrente que mais contribui para este acréscimo de pH corresponde à corrente proveniente da água de purga, visto esta apresentar um valor de pH de 12,22. De maneira a contornar os parâmetros enunciados, é proposto a substituição do filtro de areia da Sala de Bombagem, assim como a inserção de um conjunto de medidas de remoção de ferro e desinfecção, sendo a conjugação de arejamento, coagulação, filtração e desinfecção, por parte do hipoclorito, a proposta apresentada. Aos condensados dos compressores é apresentado um sistema de separação, que possibilita a remoção do óleo da água, e uma consequente descarga da mesma. Actualmente, não existe qualquer filtro de areia no circuito de arrefecimento da água, sendo proposto assim esse equipamento, de forma a minorar o desenvolvimento da população microbiana, bem como a permitir uma maior eficiência na transferência de calor na torre de arrefecimento. Relativamente à descarga industrial, é recomendável a colocação de um sistema de regularização automática de pH. A inserção de uma válvula de três vias permite um aproveitamento energético e de água, a partir da confluência da água oriunda dos furos com a água do tanque de água fria, sendo posteriormente alimentada à central de vácuo. No estudo da recuperação energética, um outro equipamento avaliado correspondeu à serpentina, no entanto, verificou-se que a poupança no consumo de gás natural era de apenas 0,005%, o que não se mostrou uma proposta viável. O orçamento de todos os equipamentos é de 11.720,76 €, possibilitando não só um melhor funcionamento industrial, como um menor impacto a nível ambiental. Os custos futuros de funcionamento aumentam em 3,36%, tendo a pressurização um aumento do seu custo em 3,4% em relação ao custo actual, verificando-se um custo anual de 10.781,21€, em relação aos processos de arejamento, coagulação e desinfecção.

Optimização na adequação turbina-compressor numa turbina agás

Trabalho Final de Mestrado para obtenção do grau de Mestre em Engenharia Mecânica

Isolated Cleft of the Anterior Mitral Valve Leaflet

Isolated anterior mitral leaflet cleft (not associated with atrio-ventricular septal defect) is a rare cause of congenital mitral regurgitation, and the treatment consists of direct suturing of the cleft. We present a clinical case with this entity.

A Papillary Fibroelastoma of the Tricuspid Valve

Primary cardiac tumours are rare in children. Of these, papillary fibroelastomas are unusual but benign, usually being found in adults. There are only sporadic cases reported in children. We diagnosed such a papillary fibroelastoma involving the tricuspid valve in an asymptomatic child during a routine cardiac investigation.

Mitral Valve Myxomas: an Unusual Entity

Primary tumours of the heart are uncommon entities, cardiac myxomas being the most frequent. However, mitral valve myxomas are exceptionally rare. In the last 12 years, there have been 25 myxomas diagnosed at our institution, with only two of them originating from the mitral valve. Both patients were female, the first, 25, and the second, 72 years old. The younger patient was very symptomatic with a large mass, 4 cm long, which involved both leaflets causing significant obstruction to the left ventricular inflow. The second one had a smaller mass located at the atrial side of the posterior leaflet that only produced some flow divergence. Neither of them had constitutional nor embolic symptoms. Both patients were submitted to emergent surgical resection that in the first case involved the mitral valve and replacement with mechanical prosthesis. The macroscopic appearance of these tumours suggested a malignant aetiology which may represent somewhat different features of the myxomas when originating from the cardiac valves. Both patients are well reflecting the good prognosis of this illness after resection, although the younger patient was re-operated because of prosthetic valve obstruction and suspicion of recurrence that was not confirmed. Because of the illustrative images and different presentations, we found it interesting to report and discuss them together.

Prosthetic Mitral Valve Thrombosis in Pregnancy: From Thrombolysis to Anticoagulation

INTRODUCTION: Pregnant women with mechanical prosthetic heart valves are at increased risk for valve thrombosis. Management decisions for this life-threatening complication are complex. Open-heart surgery has a very high risk of maternal mortality and fetal loss. Bleeding and embolic risks associated with thrombolytic agents, the limited efficacy of thrombolysis in certain subgroups, and a lack of experience in the setting of pregnancy raise important concerns. CASE REPORT: We report a case of mitral prosthetic valve thrombosis in early pregnancy, which was successfully treated with streptokinase. Ten years later, the same patient had an uneventful pregnancy, throughout which acenocoumarol was maintained. CONCLUSION: With this case we review the prevention (with oral anticoagulant therapy) and treatment of prosthetic valve thrombosis during pregnancy, which is important for both obstetrician and cardiologist.

Percutaneous Treatment of Mitral Valve Regurgitation: Initial Experience with the MitraClip Device

INTRODUCTION: Mitral regurgitation (MR) is the most common valvular disease and has recently become the target of a number of percutaneous approaches. The MitraClip is virtually the only device for which there is considerable experience, with more than 20,000 procedures performed worldwide. OBJECTIVE: To describe our initial experience of the percutaneous treatment of MR with the MitraClip device. METHODS: We describe the first six MitraClip cases performed in this institution (mean age 58.5 ± 13.1 years), with functional MR grade 4+ and New York Heart Association (NYHA) heart failure class III or IV (n=3), with a mean follow-up of 290 ± 145 days. RESULTS: Procedural success (MR ≤ 2+) was 100%. Total procedure time was 115.8 ± 23.7 min, with no in-hospital adverse events and discharge between the fourth and eighth day, and consistent improvement in the six-minute walk test (329.8 ± 98.42 vs. 385.33 ± 106.95 m) and in NYHA class (three patients improved by two NYHA classes). During follow-up there were two deaths, in two of the four patients who had been initially considered for heart transplantation. CONCLUSION: In patients with functional MR the MitraClip procedure is safe, with both a high implantation and immediate in-hospital success rate. A longer follow-up suggests that the clinical benefit decreases or disappears completely in patients with more advanced heart disease, namely those denied transplantation or on the heart transplant waiting list.

Diagnóstico pela ecocardiografia transesofágica e evolução de 35 pacientes portadores de flail mitral valve

OBJETIVO: Descrever os achados ao ecocardiograma transesofágico e evolução clínica de portadores de flail mitral valve. MÉTODOS: No período de janeiro/93 a março/97, 1675 pacientes foram submetidos, em nossa instituição, a ecocardiograma transesofágico, sendo que em 35 casos foi feito o diagnóstico de flail mitral valve e, posteriormente, obtida sua evolução clínica. RESULTADOS: A idade dos pacientes variou 12 a 87 anos (média 65±15) e 27 (77%) eram do sexo masculino. O folheto posterior foi o mais acometido (25 pacientes, 71%). O mecanismo do flail foi ruptura de cordoalha tendínea em todos os casos, exceto um, que apresentava importante alongamento e redundância de cordoalha. A etiologia foi prolapso e/ou degeneração mixomatosa em 15 pacientes, degenerativa em 9, isquêmica em 5, reumática em 4 e endocardite em 3. Regurgitação mitral de grau importante ocorreu em 25 (71%) pacientes e moderada em 10 (29%). O tempo médio de acompanhamento foi de 375±395 dias (1 a 1380). Foram submetidos a tratamento clínico 19 pacientes e a tratamento cirúrgico 16, sendo que em todos foi confirmado o diagnóstico transesofágico. O número total de óbitos (hospitalar e pós-hospitalar) foi alto (34%), tanto em pacientes submetidos a tratamento clínico quanto cirúrgico. Entre os sobreviventes, 17 estão em classe funcional (CF) I e 6 em CF II da NYHA. CONCLUSÃO: O diagnóstico de flail mitral valve ao ecocardiograma transesofágico é acurado, permitindo a definição de sua etiologia e mecanismo. A alta mortalidade à época do diagnóstico, provavelmente, se relaciona à gravidade da doença subjacente. Embora os pacientes não operados estejam evoluindo bem, a baixa CF observada nestes pacientes pode ser atribuída ao curto período de seguimento.

Mitral valve disease with rheumatic appearance in the presence of left ventricular endomyocardial fibrosis

This is a report of a nine-year-old boy with both mitral stenosis and regurgitation and extensive endomyocardial fibrosis of the left ventricle. Focus is given to the singularity of the fibrotic process, with an emphasis on the etiopathogenic aspects.

Myxoma of the mitral valve

Only rarely do myxomas originate from the mitral valve. This is the report of a 49-year-old woman presenting with congestive heart failure. The diagnosis of an intracardiac tumor involving the anterior cuspid of the mitral valve was made by transesophageal echocardiography. The patient underwent surgery for tumor resection and plasty of the valve was made with reconstruction and preservation of the valve. The diagnosis of myxoma was confirmed by histology. This is the 23rd case of myxoma of the mitral valve reported in the literature.

Aortic valve assessment. Anatomical study of 100 healthy human hearts

PURPOSE: To assess anatomical characteristics of the aortic valve, so that they may be useful in diagnostic situations and surgical treatment. METHODS: The study analyzed 100 healthy fixed human hearts; 84% of them obtained from males, 61% of them from Caucasian individuals. The ages of the individuals ranged from 9 to 86 years (mean 30±15.5 years). The characteristics assessed related to age, sex, and race were the following: number and height of the cusps, size of the lunulae, internal and external intercommissural distance, position of the coronary ostium in relation to the aortic valve, position of the ventricular septum in relation to the aortic valve, thickness of the cusps. RESULTS: All hearts assessed had a tricuspidal aortic valve. In regard to the height of the cusps and size of the lunula, the left coronary cusp was larger, followed by the right coronary cusp and the noncoronary cusp. The internal and external intercommissural distances had mean values of 24.6±5.7mm and 19.7±7mm, respectively. In regard to the position of the coronary ostia, in one heart two ostia emerged from the left coronary sinus, and in another, the ostium was supracommissural. The mean diameter of the aorta was 21.8±3.6mm, and there were no significant sexual or racial differences, but the diameter increased progressively with the increase in age. The thickness of the cusps did not show any significant difference in the 3 points assessed. CONCLUSION: The aortic valve annulus did not show a perfect circumference, with some variations in the measurements of the annulus, in the cusps and in the relation with the ventricular septum.

Mitral valve repair. Quadrangular resection of the posterior leaflet in patients with myxomatous degeneration

OBJECTIVE - To analyze the immediate and late results of mitral valve repair with quadrangular resection of the posterior leaflet without the use of a prosthetic ring annuloplasty. METHODS - Using this technique, 118 patients with mitral valve prolapse who underwent mitral repair from January '84 through December '96 were studied. Age ranged from 30 to 86 (mean = 59.1±11.8) years and 62.7% were males. An associated surgery was performed in 22% of the patients, and coronary artery bypass graft was the most frequently performed surgery (15 patients - 12.7%). In 20 (16.9%) patients other associated techniques of mitral valve repair were used and shortening of elongated chordae tendineae was the most frequent one (6 patients). RESULTS - Immediate mortality was 0.9% (one patient). Long-term rates for thromboembolism, endocarditis, re-operation and death in the late postoperative period were 0.4%, 0.4%, 1.7% and 2.2% patients/year, respectively. The actuarial curve of survival was 83.8±8.6% over 12 years; survival free from re-operation was 91.8±4.3%, free from endocarditis was 99.2±0.8% and free from thromboembolism was 99.2±0.8%. In the late postoperative period, 93.8% of the patients were in functional class 1 (NYHA), with a complete follow-up in 89.7% of the patients. CONCLUSION - Patients with mitral valve prolapse who undergo mitral valve repair using this technique have a satisfactory prognosis over 12 years.